Medindia

X

Caliper Life Sciences' Second Quarter 2008 Financial Results Conference Call Notice

Thursday, July 24, 2008 General News J E 4
Advertisement
HOPKINTON, Mass., July 23 Caliper Life Sciences,Inc. (Nasdaq: CALP) will conduct a conference call discussing the company'ssecond quarter 2008 financial results at 9:00 a.m. EDT on Wednesday, August 6.Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, ChiefFinancial Officer, will host the call. Management will discuss operational andfinancial results and the company's outlook for the future.

A news release discussing Caliper's second quarter 2008 financial resultswill be issued Wednesday, August 6 at approximately 7:00 a.m. EDT.

Participants, please call 888.713.4215 five to ten minutes prior to thecall and use the participant passcode of 30981927. International callers canaccess the call by dialing 617.213.4867 and entering the same passcode. Youmay also pre-register for the call athttps://www.theconferencingservice.com/prereg/key.process?key=PALUYGE6Q .

A live webcast of the call can be accessed at www.fulldisclosure.com or onthe Caliper website at www.caliperLS.com in the Events section of the InvestorRelations page. A webcast replay of the call will remain available untilCaliper's earnings call for the third quarter of 2008.

Telephone replays of the conference call will be available approximatelytwo hours after the completion of the call. To access a telephone playback ofthe proceedings from August 6 through August 13, dial 888-286-8010 and usethe participant passcode of 48521551. International callers can access theplayback by dialing 617-801-6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologiesenabling researchers in the life sciences industry to create life-saving andenhancing medicines and diagnostic tests more quickly and efficiently. Caliperis aggressively innovating new technology to bridge the gap between in vitroassays and in vivo results and then translating those results into cures forhuman disease. Caliper's portfolio of offerings includes state-of-the-artmicrofluidics, lab automation & liquid handling, optical imaging technologies,and discovery & development outsourcing solutions. For more information pleasevisit http://www.caliperLS.com.

SOURCE Caliper Life Sciences, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Cardiome Announces Preferred Share Financing
S
YMCA Calls on Senate to Fund Community-Based Solut...